Target intelligence / Profile preview

Conjugated bile salt

Molecular classification
Other (amphipathic steroid-derived metabolites)
01

Overview

Conjugated bile salts are small amphipathic molecules formed in the liver by the covalent linkage of a primary bile acid (such as cholic acid or chenodeoxycholic acid) with either glycine or taurine at the carboxyl group. This conjugation increases water solubility and prevents precipitation at physiological and lower pH, allowing the molecules to serve as effective natural detergents in the small intestine. They play a critical role in digestion and absorption of fats and fat-soluble vitamins by forming mixed micelles, and they are the main mechanism for eliminating excess cholesterol from the body. Conjugated bile salts also have roles as ligands for certain nuclear hormone receptors (such as FXR, TGR5), but the salts themselves are not direct protein targets. Alterations in their levels or metabolism are associated with liver and gastrointestinal diseases, and pharmacological manipulation of bile salt pools is the basis for some drugs treating dyslipidemia and cholestasis.

Other names
Bile saltconjugated bile acidtaurocholateglycocholatetaurochenodeoxycholateglycochenodeoxycholate
02

Mechanism of action

Sequestrants bind bile salts to reduce reabsorption and lower cholesterol Bile acid analogs replace toxic/endogenous bile acids in cholestasis

03

Biological functions

Solubilization and absorption of dietary lipidsFacilitation of cholesterol excretionFormation of micelles for nutrient uptakeModulation of gut microbiotaRegulation of cholesterol homeostasis
04

Disease associations

Cholestatic liver diseaseGallstone formationInflammatory bowel disease (altered composition)Fat malabsorption syndromesPotential impact in certain metabolic and liver disorders
05

Safety considerations

Excessive bile salt accumulation can cause hepatotoxicity and cholestatic injuryDisruption of enterohepatic recirculation may cause fat-soluble vitamin deficiencies or gastrointestinal disturbances
06

Interacting drugs

Ursodeoxycholic acid (pharmacological bile acid analog)

3 more in the full profile.

07

Biomarkers

Serum bile salt concentration as biomarker of cholestasis, liver dysfunctionFecal bile salt profile in malabsorption syndromes

Beyond the preview

Go deeper on Conjugated bile salt.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conjugated bile salt.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call